Kathryn Kniele, PHD | |
1744 Sam Rittenberg Blvd, Suite A3, Charleston, SC 29407-4935 | |
(843) 278-7716 | |
(843) 278-7716 |
Full Name | Kathryn Kniele |
---|---|
Gender | Female |
Speciality | Psychologist - Clinical |
Location | 1744 Sam Rittenberg Blvd, Charleston, South Carolina |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1356369664 | NPI | - | NPPES |
PS0426 | Medicaid | SC |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TC0700X | Psychologist - Clinical | 1026 (South Carolina) | Primary |
103G00000X | Clinical Neuropsychologist | 1026 (South Carolina) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Kathryn Kniele, PHD 1744 Sam Rittenberg Blvd, Suite A3, Charleston, SC 29407-4935 Ph: (843) 278-7716 | Kathryn Kniele, PHD 1744 Sam Rittenberg Blvd, Suite A3, Charleston, SC 29407-4935 Ph: (843) 278-7716 |
News Archive
The leader of the nation's largest veterans organization called a senior VA official's concession during a congressional hearing tonight that the department has an accountability problem "one of the understatements of the year."
The U.S. Food and Drug Administration (FDA) is expected to respond by March 31 to a petition from the Natural Resources Defense Council (NRDC) to ban the chemical bisphenol A (BPA) from food-contact materials. Shatter-resistant polycarbonate plastic and durable epoxy resins, both made from BPA, are approved by the FDA and commonly used in reusable containers and food packaging.
Nearly one-third of breast cancer survivors who were working when they began treatment were unemployed four years later. Women who received chemotherapy were most affected, according to a new study from the University of Michigan Comprehensive Cancer Center.
Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Biocon, Limited (NSE: BIOCON) announced today that they have entered into an exclusive agreement to jointly develop, commercialize and manufacture a novel peptide therapeutic for the potential treatment of diabetes. Amylin and Biocon will collaborate to develop the therapeutic potential of the compound and share development costs. Research will center on Amylin's "phybrid" technology.
› Verified 8 days ago
Dr. Anna Birks, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 109 Bee Street, Charleston, SC 29401 Phone: 843-789-7316 | |
Christine Reineke Bachmann, PSY.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 1 Poston Rd, Suite 145, Charleston, SC 29407 Phone: 843-556-4157 Fax: 843-763-8747 | |
Dr. Janet Rose, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 215 E Bay St, Suite 501, Charleston, SC 29401 Phone: 843-708-4308 Fax: 843-723-8324 | |
Dr. Kathryn Reid, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1016 Telfair Way, Charleston, SC 29412 Phone: 804-338-1820 | |
Mrs. Angela Geddes, ED.S. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 505 Arlington Dr, Charleston, SC 29414 Phone: 843-606-0136 | |
Dr. Ashley Marie Fowler, PSYD. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1525 Sam Rittenberg Blvd Ste 103, Charleston, SC 29407 Phone: 509-680-0093 | |
David Brian Haver Jr., PSYD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 |